Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
25.87M | 2.67M | 6.01M | 12.44M | 60.06M | Gross Profit |
-1.00M | 60.17K | 551.40K | 1.78M | 25.35M | EBIT |
-2.43M | -2.18M | -2.98M | 2.15M | -5.76M | EBITDA |
-2.04M | -2.06M | -3.16M | -8.34M | -2.14M | Net Income Common Stockholders |
-6.28M | -3.03M | -6.18M | -20.12M | -5.15M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.03M | 1.55M | 3.04M | 4.26M | 8.23M | Total Assets |
4.37M | 6.37M | 10.08M | 17.34M | 45.40M | Total Debt |
2.19M | 0.00 | 520.24K | 3.06M | 15.56M | Net Debt |
206.65K | -1.39M | -2.52M | -1.21M | 7.33M | Total Liabilities |
3.80M | 1.26M | 5.98M | 11.98M | 29.37M | Stockholders Equity |
524.74K | 5.11M | 4.13M | 5.39M | 16.03M |
Cash Flow | Free Cash Flow | |||
-2.84M | -3.46M | -5.35M | -10.48M | -2.92M | Operating Cash Flow |
-2.66M | -3.46M | -4.64M | -7.99M | 3.01M | Investing Cash Flow |
-318.20K | -192.52K | -159.08K | -2.59M | -5.87M | Financing Cash Flow |
3.58M | 2.00M | 4.72M | 6.59M | 1.07M |
AuMake Limited has announced the expiration of its quoted options, exercisable at $0.045 each, effective 31 May 2025. The company highlights that these options are significantly out of the money, with the highest market price of its shares in the past six months being $0.007, and the lowest at $0.003. As a result, the company will not dispatch personalized notices to option holders. If all options were exercised, 75,500,000 fully paid ordinary shares would be issued. However, without payment by the expiry date, the options will expire unexercised, and all rights will cease.
AuMake Limited announced a change in the director’s interest, with Jiahua (Joshua) Zhou converting 4,666,667 zero exercise price options into fully paid ordinary shares. This change increases Zhou’s holdings to 117,560,672 ordinary shares, reflecting a strategic move in the company’s stock management.
AuMake Ltd. has announced the issuance of fully paid ordinary shares without disclosure under Part 6D.2 of the Corporations Act, as per the notice under section 708A(5)(e). The company has complied with the necessary provisions of the Corporations Act, ensuring transparency and adherence to legal requirements, which is crucial for maintaining investor confidence and operational integrity.
AuMake Limited has announced the quotation of 12,666,667 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from April 30, 2025. This move is part of the company’s strategic financial operations, potentially impacting its market presence and offering new opportunities for investors.
AuMake Limited reported significant growth in cash receipts for Q3 FY25, with a 160% increase compared to the previous year and an 11% rise from the previous quarter. The company has executed new partnership agreements, including deals with Sichuan Airlines E-Commerce and Kabrita, which are expected to drive future sales growth. Operational improvements have led to a 75% reduction in net cash used in operations. The company is focused on cash flow management and aims to achieve break-even while maintaining sales growth.
AuMake Limited’s subsidiary, 168 Express Pty Ltd, has filed a Statement of Claim in the District Court of NSW against iRich Foods Pty Ltd and its director, Mr. Weifeng Chen, for the recovery of a $678k deposit. The company is confident in successfully recovering the deposit and legal costs from the defendants, which could positively impact its financial standing and reassure stakeholders of its proactive legal measures.
Aumake Limited has announced a significant reduction in board fees and executive director salaries, resulting in annual savings of over $400,000. This decision is part of a broader initiative to review and reduce the company’s fixed cost base, aiming to achieve cash flow positivity and profitability. The company is focusing on maximizing cash utilization to support growth in key sales channels and launching new products, especially as it forms new higher-margin brand partnerships. Aumake sees strong growth potential in China and is well-positioned to deliver long-term value to shareholders through strategic efficiency and financial discipline.
Aumake Limited has secured an exclusive distribution agreement for Kabrita High-Calcium Adult Goat Milk Powder in Australia and New Zealand, effective until December 2027. This strategic partnership allows Aumake to expand its footprint in the functional food sector and capitalize on the growing demand for premium nutrition products in these regions. The agreement enhances Aumake’s portfolio and positions the company to potentially form similar partnerships with other global health and nutrition brands in the future.
Aumake Limited has entered a strategic distribution agreement with Henan Wanbang Huinong Supply Chain Management Co., a major Chinese private distributor. This partnership significantly enhances Aumake’s market reach and revenue stability in China by providing a structured and scalable entry into the retail and wholesale markets. The agreement allows Aumake to maintain pricing control and adapt to market trends through regular sales data and insights, ensuring sustained revenue growth and competitive differentiation in China’s premium imported goods sector.
AuMake Limited has announced an update regarding the proposed quotation of its options, as detailed in a prospectus dated March 10, 2025. The update includes a distribution schedule and a report on the top 20 holders of these options, which are set to expire on October 23, 2026. This move is likely to impact the company’s market positioning by potentially increasing liquidity and attracting more investors, as evidenced by significant holdings from entities like Zoomcoo Holdings Pty Ltd and Sovereign International Pty Ltd.
AuMake Limited has announced a new issuance of quoted options, set to expire on October 23, 2026, with a total of 1,036,285,358 securities to be quoted. This development could potentially impact AuMake’s market positioning by providing additional liquidity and investment opportunities, which may influence stakeholder engagement and the company’s future financial strategies.
Zoomcoo Holding Pty Ltd has become a substantial holder in AuMake Limited, acquiring a 9.071% voting power through the direct ownership of 273,114,000 fully paid ordinary shares. This acquisition, completed on October 23, 2024, signifies a significant stake in AuMake Limited, potentially impacting the company’s strategic direction and shareholder dynamics.
AuMake Limited has announced an options prospectus for the offer of up to 10,000 listed options at no consideration to remove trading restrictions on the sale of all listed options issued or quoted on the ASX by the company before the closing date. This move is aimed at enhancing liquidity and flexibility in trading the company’s options, with the offer closing on March 11, 2025. The options are considered speculative, and the offer is not underwritten, indicating a strategic approach to manage the company’s market presence and investor engagement.
Aumake Limited has appointed Dr. Anthony Noble as the Non-Executive Chairman to spearhead its strategic growth initiatives. Dr. Noble’s extensive experience in eCommerce, international market expansion, and product development is expected to drive Aumake’s focus on premium products for the Chinese market, enhancing shareholder value and positioning the company as a key player in the health, wellness, and beauty segments.
AuMake Limited reported a 19% decrease in revenues for the half-year ended December 31, 2024, compared to the same period in 2023, with revenues totaling $13.57 million. The company’s loss from ordinary activities after tax increased by 42% to $1.93 million. No dividends were declared or paid during this period. Despite the financial downturn, the net tangible assets per ordinary security increased to 0.14 cents from 0.07 cents, and the company expanded its investment portfolio by establishing a joint venture in the wine and tourism industry.